04 August 2008 London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY)
notifies the market that the Company's issued share capital consists
of 613,565,378 ordinary shares with voting rights. Antisoma does not
hold any ordinary shares in Treasury.
Therefore, the total number of voting rights in Antisoma is
The above figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, Antisoma
under the FSA's Disclosure and Transparency Rules.
Daniel Elger, Director of Communications
+44 (0)20 3249 2100
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company
that develops novel products for the treatment of cancer. The Company
has operations in the UK and the US. Please visit www.antisoma.com
for further information about Antisoma.
---END OF MESSAGE---